Select a section from the left sidebar
1-hexacosene
- Family: Plantae - Polygonaceae
- Kingdom: Plantae
- Class: Fatty Acid
Canonical Smiles | CCCCCCCCCCCCCCCCCCCCCCCCC=C |
---|---|
InChI | InChI=1S/C26H52/c1-3-5-7-9-11-13-15-17-19-21-23-25-26-24-22-20-18-16-14-12-10-8-6-4-2/h3H,1,4-26H2,2H3 |
InChIKey | OMXANELYEWRDAW-UHFFFAOYSA-N |
Formula | C26H52 |
HBA | 0 |
HBD | 0 |
MW | 364.7 |
Rotatable Bonds | 23 |
TPSA | 0.0 |
LogP | 10.16 |
Number Rings | 0 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Fraction CSP3 | 0.92 |
Exact Mass | 364.41 |
Number of Lipinski Rule Violations | 1 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Rumex pictus | Polygonaceae | Plantae | 1786036 |
Showing of synonyms
1-hexacosene
Hexacos-1-ene
HEXACOSENE
UNII-MSG4U9AQ89
MSG4U9AQ89
EINECS 242-615-9
AI3-10513
DTXSID80873052
EC 242-615-9
64808-91-9
DTXCID409835
DTXSID501015015
Omxanelyewrdaw-uhfffaoysa-n
18835-33-1
1-?Hexacosene(>85%)
1-?Hexacosene
CHEBI:184289
TAA83533
LMFA11000320
NS00005393
F87219
Q27284213
- Ammar M.N, Ayoub A.N, et al. (2015). Phytochemical and Cytotoxic Studies of Rumex pictus Forssk. and Rumexvesicarius L.(Family Polygonaceae), Growing in Egypt. European Journal of Medicinal Plants, 2015, 10(3), 1-13. [View]
No compound-protein relationship available.
No scaffolds available.
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -5.29
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -3.81
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- -3.94
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 2.94
- Plasma Protein Binding
- 26.79
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 3.28
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Safe
- Bioconcentration Factor
- 1.96
- Biodegradation
- Toxic
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Toxic
- Eye Irritation
- Toxic
- Maximum Tolerated Dose
- 1.89
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 5.09
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- 7.74
- Rat (Acute)
- 1.3
- Rat (Chronic Oral)
- 2.86
- Fathead Minnow
- 4.66
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 412.21
- Hydration Free Energy
- -0.49
- Log(D) at pH=7.4
- 7.65
- Log(P)
- 13.88
- Log S
- -6.98
- Log(Vapor Pressure)
- -6.7
- Melting Point
- 38.46
- pKa Acid
- 11.97
- pKa Basic
- 8.54
No predicted protein targets found for this compound.